NCT00598962

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: The University of Texas Health Science Center at Tyler · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To determine the safety and efficacy of azithromycin, rifabutin and ethambutol given three times weekly in the treatment of lung infection with M. avium complex(MAC)

Detailed description

Azithromycin given 3 times weekly along with rifampin/rifabutin and ethambutol for treatment of MAC

Conditions

• Mycobacterium Avium Complex

Interventions

Type	Name	Description
DRUG	Azithromycin	Dosage dependent on clinical factors such as age, weight and patient-specific health status
DRUG	Rifabutin/rifampin

Timeline

• Start date: 1994-12-01
• Primary completion: 2006-11-01
• Completion: 2017-05-18
• First posted: 2008-01-23
• Last updated: 2017-05-23

Locations

1 site across 1 country: United States